Repercussions of social isolation arising from the COVID-19 pandemic on signs and symptoms of elderly people with Parkinson´s disease: integrative review
DOI:
https://doi.org/10.11606/issn.2317-0190.v31i1a209353Keywords:
Parkinson Disease, Social Isolation, COVID-19, AgedAbstract
Objective: To review the literature on the consequences of social isolation resulting from the COVID-19 pandemic on motor and non-motor signs and symptoms of elderly people with Parkinson's disease (PD). Method: This is an integrative review with a search in the following databases: PUBMED, LILACS and SCOPUS with filter for publications (November 2019), being proportional to the beginning of the COVID-19 outbreak (year 2020). Studies available in Portuguese, English or Spanish were included, with the elderly population (≥60 years) with PD, which assessed social isolation resulting from the pandemic as exposure and motor and/or non-motor symptoms of PD as an outcome. Studies that did not answer the guiding question and that did not comply with the proposed criteria were excluded. To analyze the methodological quality and the level of evidenced articles, the Critical Appraisal Skill Program and Agency for Health care and Research and Quality instruments were applied. To summarize the motor and non-motor signs and symptoms that worsened during social isolation, a coding criterion inspired by previous studies was used. Results: The final sample resulted in 8 articles. Elderly PD patients faced worsening motor symptoms, especially tremor and rigidity, and non-motor symptoms such as anxiety, depression, and fatigue. Conclusion: Social isolation resulting from the COVID-19 pandemic may have worsened the motor and non-motor symptoms of elderly people with Parkinson's disease. Therefore, it is important to implement multidisciplinary interventions, with a different perspective and care from the rehabilitation team in order to prevent biopsychosocial problems.
Downloads
References
Organização Pan-Americana da Saúde/Organização Mundial da Saúde. Doença causada pelo novo coronaví-rus (COVID-19) [texto na Internet]. São Paulo: OPAS/OMS; c2021 Acesso em [citado 2021 fev 12]. Dis-ponível em: https://www.paho.org/pt/topicos/coronavirus/doenca-causada-pelo-novo-coronavirus-covid-19
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. Doi: https://doi.org/10.1056/NEJMoa2001017
Flint AJ, Bingham KS, Iaboni A. Effect of COVID-19 on the mental health care of older people in Canada. Int Psychogeriatr. 2020;32(10):1113-1116. Doi: https://doi.org/10.1017/S1041610220000708
Haider, II, Tiwana, F, Tahir, SM. Impacto da pandemia COVID-19 na saúde mental de adultos. Pak J Med Sci. 2020;36(COVID19-S4). Doi: https://doi.org/10.12669/pjms.36.COVID19-S4.2756
Instituto Brasileiro de Geografia e Estatística. Longevidade: viver bem e cada vez mais. Retratos: a revista do IBGE. 2019;(16):3-27.
Garcia filho C, Vieira LJEDS, Silva RMD. Buscas na internet sobre medidas de enfrentamento à COVID-19 no Brasil: descrição de pesquisas realizadas nos primeiros 100 dias de 2020. Epidemiol Serv Saúde. 2020;29 (3). Doi: https://doi.org/10.5123/S1679-49742020000300011
Macuglia GR, Rieder CRDM, Almeida RMMD. Funções executivas na doença de Parkinson: revisão da literatura. Psico. 2012;43(4):552-61.
Helmich RC, Bloem BR. The Impact of the COVID-19 Pandemic on Parkinson's Disease: Hidden Sorrows and Emerging Opportunities. J Parkinsons Dis. 2020;10(2):351-54. Doi: https://doi.org/10.3233/JPD-202038
Victorino DB, Guimarães-Marques M, Nejm M, Scorza FA, Scorza CA. COVID-19 and Parkinson's Disease: Are We Dealing with Short-term Impacts or Something Worse? J Parkinsons Dis. 2020;10(3):899-902. Doi: https://doi.org/10.3233/JPD-202073
Mendes KS, Silveira RCCP, Galvão CM. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & Contexto Enferm. 2008;17(4):758-64. Doi: https://doi.org/10.1590/S0104-07072008000400018
Critical Appraisal Skills Programme (CASP) [homepage on the Internet]. Oxford: CASP; c2023 [cited 2023 Feb 5]. Available from: https://casp-uk.net
Melnyk BM, Fineout-Overholt E, Stillwell SB, Williamson KM. Evidence-based practice: step by step: the seven steps of evidence-based practice. Am J Nurs. 2010;110(1):51-3. Doi: https://doi.org/10.1097/01.NAJ.0000366056.06605.d2
Vancampfort D, Mugisha J, Richards J, De Hert M, Probst M, Stubbs B. Physical activity correlates in people living with HIV/AIDS: a systematic review of 45 studies. Disabil Rehabil. 2018;40(14):1618-1629. Doi: https://doi.org/10.1080/09638288.2017.1306587
Silva TAM, Silva LP, Faccio PF, Silva KMC, Arruda ARV, Silva LN, et al. Análise dos parâmetros espaçotemporais da marcha em indivíduos com disfunção neurológica tratados com prática mental: uma revisão sistemática. Acta Fisiátr. 2018;25(2):86-93. Doi: https://doi.org/10.11606/issn.2317-0190.v25i2a162567
Arruda NBM, Silva SRA, Asano NMJ, Coriolano MGWS. Estado nutricional de idosos com doença de Parkinson e seus fatores associados: uma revisão integrativa. Rev Bras Geriatr Gerontol. 2020;23(5). Doi: https://doi.org/1590/1981-22562020023.200254
Salari M, Zali A, Ashrafi F, Etemadifar M, Sharma S, Hajizadeh N, et al. Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease (COVID-19) Pandemic. Mov Disord. 2020;35(7):1095-1096. Doi: https://doi.org/10.1002/mds.28116
Shalash A, Roushdy T, Essam M, Fathy M, Dawood NL, Abushady EM, et al. Mental Health, Physical Activity, and Quality of Life in Parkinson's Disease During COVID-19 Pandemic. Mov Disord. 2020;35(7):1097-1099. Doi: https://doi.org/10.1002/mds.28134
van der Heide A, Meinders MJ, Bloem BR, Helmich RC. The Impact of the COVID-19 Pandemic on Psychological Distress, Physical Activity, and Symptom Severity in Parkinson's Disease. J Parkinsons Dis. 2020;10(4):1355-1364. Doi: https://doi.org/10.3233/JPD-202251
Schirinzi T, Cerroni R, Di Lazzaro G, Liguori C, Scalise S, Bovenzi R, et al. Self-reported needs of patients with Parkinson's disease during COVID-19 emergency in Italy. Neurol Sci. 2020;41(6):1373-1375. Doi: https://doi.org/10.1007/s10072-020-04442-1
Prasad S, Holla VV, Neeraja K, Surisetti BK, Kamble N, Yadav R, et al. Impact of Prolonged Lockdown due to COVID-19 in Patients with Parkinson's Disease. Neurol India. 2020;68(4):792-795. Doi: https://doi.org/10.4103/0028-3886.293472
Brown EG, Chahine LM, Goldman SM, Korell M, Mann E, Kinel DR, et al. The Effect of the COVID-19 Pandemic on People with Parkinson's Disease. J Parkinsons Dis. 2020;10(4):1365-1377. Doi: https://doi.org/10.3233/JPD-202249
Santos-García D, Oreiro M, Pérez P, Fanjul G, Paz Gon-zález JM, Feal Painceiras MJ, et al. Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross-Sectional Survey of 568 Spanish Patients. Mov Disord. 2020;35(10):1712-1716. Doi: https://doi.org/10.1002/mds.28261
Subramanian I, Farahnik J, Mischley LK. Synergy of pandemics-social isolation is associated with worsened Parkinson severity and quality of life. NPJ Parkinsons Dis. 2020;6:28. Doi: https://doi.org/10.1038/s41531-020-00128-9
Coriolano MGWS, Silva EG, Fortuna ES, Asano A, Mon-teiro D, Lins OG. Perfil epidemiológico dos pacientes com doença de Parkinson do Hospital das Clínicas da Univer-sidade Federal de Pernambuco. Neurobiologia. 2013; 76(1-2):19-28.
Naderi F, Roushani KH. The Relations between Spiritual Intelligence, Social Intelligence and Death Anxiety in Ahwaz WomanSeniles. J Women Cult. 2011;2(6):55–67.
Ryan J, Scali J, Carrière I, Scarabin PY, Ritchie K, Ancelin ML. Variantes do gene do receptor de estrogênio estão associadas a transtornos de ansiedade em mulheres mais velhas. Psychoneuroendocrinology. 2011;36(10):1582–1586. Doi: https://doi.org/10.1016/j.psyneuen.2011.04.011
Broen MP, Narayen NE, Kuijf ML, Dissanayaka NN, Leentjens AF. Prevalence of anxiety in Parkinson's dis-ease: A systematic review and meta-analysis. Mov Dis-ord. 2016;31(8):1125-33. Doi: https://doi.org/10.1002/mds.26643
Carod-Artal FJ, Ziomkowski S, Mourão Mesquita H, Martínez-Martin P. Anxiety and depression: main determinants of health-related quality of life in Brazilian pa-tients with Parkinson's disease. Parkinsonism Relat Di-sord. 2008;14(2):102-8. Doi: https://doi.org/10.1016/j.parkreldis.2007.06.011
Brasil. Ministério da Saúde. Envelhecimento e saúde da pessoa idosa. Brasília (DF): Ministério da Saúde; 2007. [Série A. Normas e Manuais Técnicos / Cadernos de Atenção Básica; n. 19]
Reijders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord. 2008;23(2):183-9. Doi: https://doi.org/10.1002/mds.21803
Chagas MH, Moriyama TS, Felício AC, Sosa AL, Bres-san RA, Ferri CP. Depression increases in patients with Parkinson’s disease according to the increasing severity of the cognitive impairment. Arq Neuropsiquiatr. 2014;72(6):426-9. Doi: https://doi.org/10.1590/0004-282x20140049
Schrag A, Taddei RN. Chapter Twenty - Depression and Anxiety in Parkinson's Disease. Int Rev Neurobiol. 2017;133:623-55. Doi: https://doi.org/10.1016/bs.irn.2017.05.024
Stocchi F, Abbruzzese G, Ceravolo R, Cortelli P, D'Amelio M, Pandis MF, et al. Prevalence of fatigue in Parkinson disease and its clinical correlates. Neurology. 2014;83(3):215-20. Doi: https://doi.org/10.1212/WNL.0000000000000587
Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, et al. The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord. 2009;24(11):1641-9. Doi: https://doi.org/10.1002/mds.22643
Siciliano M, Trojano L, Santangelo G, De Micco R, Tedeschi G, Tessitore A. Fatigue in Parkinson's disease: A systematic review and meta-analysis. Mov Disord. 2018;33(11):1712-1723. Doi: https://doi.org/10.1002/mds.27461
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Acta Fisiátrica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
